Study of the Therapeutic Effects of Intercessory Prayer (STEP)
NCT ID: NCT00179491
Last Updated: 2007-11-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1802 participants
INTERVENTIONAL
1998-04-30
2001-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
604 patients received intercessory prayer after being informed they may or may not receive prayers (Group 1)
Intercessory Prayer
14 days of intercessory prayer from 3 sites
2
597 patients did not receive prayer after being informed they may or may not receive prayer (Group 2)
No interventions assigned to this group
Group 3
601 patients received intercessory prayer after being informed they would receive it (Group 3).
Intercessory Prayer
14 days of intercessory prayer from 3 sites
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intercessory Prayer
14 days of intercessory prayer from 3 sites
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to read or understand English
Exclusion Criteria
* CABG more than 14 days after enrollment
* Other planned surgery within 30 days of CABG
* Minimally invasive CABG (non full sternotomy incisions)
* CABG with planned valve replacement, stent, angioplasty or carotid endarterectomy
* Or had ongoing chest pain or unstable angina, as defined by their physicians
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
John Templeton Foundation
OTHER
INTEGRIS Baptist Medical Center
OTHER
Medstar Health Research Institute
OTHER
Baptist Memorial Health Care Corporation
OTHER
Mayo Clinic
OTHER
Beth Israel Deaconess Medical Center
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Herbert Benson, MD
Role: PRINCIPAL_INVESTIGATOR
Beth Israel Deaconess Medical Center, Mind/Body Medical Institute
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2001-P-002125
Identifier Type: -
Identifier Source: org_study_id